BioVie Inc
Change company Symbol lookup
Select an option...
BIVI BioVie Inc
FRSHY China Jinmao Holdings Group Ltd
EQH-C Equitable Holdings Inc
IBTX Independent Bank Group Inc
DLTR Dollar Tree Inc
FRTX Fresh Tracks Therapeutics Inc
PLXS Plexus Corp
YEXT Yext Inc
UPWK Upwork Inc
NEGG Newegg Commerce Inc
Go

Health Care : Biotechnology | Small Cap Value
Company profile

BioVie Inc. is a clinical-stage company. The Company is developing drug therapies to treat chronic debilitating conditions, including liver disease and neurological and neuro-degenerative disorders and certain cancers. In liver disease, the Company's orphan drug candidate BIV201 (continuous infusion terlipressin) is developed as a future treatment option for patients suffering from ascites and other life-threatening complications of advanced liver cirrhosis caused by nonalcoholic steatohepatitis (NASH), hepatitis, and alcoholism. The Company is also engaged in developing NE3107, an extracellular single-regulated kinase (ERK) inhibitor that selectively reduces neuroinflammation and insulin resistance. NE3107 is an orally administered small molecule to inhibit inflammation-driven insulin resistance and pathological inflammatory cascades.

Closing Price
$5.05
Day's Change
0.02 (0.40%)
Bid
--
Ask
--
B/A Size
--
Day's High
5.17
Day's Low
4.88
Volume
(Light)
Volume:
213,733

10-day average volume:
287,757
213,733
  • Prev Close
    5.03
  • Today's Open
    5.00
  • Day's Range
    4.88-5.17
  • Avg Vol (10-day)
    287.8K
  • Last (time)
    4:00p ET 01/27/23
  • Last (size)
    20
  • 52-Wk Range
    1.33 - 14.38
    LowHigh
  • (07/01/22 - 12/16/22)
    281.13%
  • 138.7%
  • Market Cap
    164.0M
  • Shares Outstanding
    32.5M
  • -1.21
  • --
  • No dividend
  • Ex-dividend Date
    No dividend
  • Dividend Pay Date
    No dividend
  • 2.8
  • 2.09
  • (% of float 01/15/23)
    4.54

Latest News

January 25, 2023
8:01 am ET
Accesswire
December 29, 2022
8:30 am ET
Accesswire
December 13, 2022
8:07 am ET
Accesswire
December 08, 2022
4:25 pm ET
MarketWatch
December 07, 2022
11:19 am ET
PR Newswire
8:00 am ET
Globe Newswire
December 06, 2022
6:00 am ET
Globe Newswire
December 05, 2022
5:00 pm ET
Globe Newswire
November 29, 2022
8:00 am ET
Globe Newswire
November 15, 2022
8:00 am ET
Globe Newswire
September 07, 2022
6:20 am ET
MarketWatch
Go to all current & historical news

Earnings Calendar and Events Data provided by |Terms of Use| © 2023 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2023. All rights reserved.